SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

VitaSpring Biomedical Co. Ltd. (VSBC) News

Follow VitaSpring Biomedical Co. Ltd. (VSBC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VSBC Asset equity Sector Markets 90 days 2 Last 0.0155 Updated Sep 17, 2026, 05:34 PM UTC Open live news feed Open VSBC chart & news
M Vitaspring Biomedical posts zero revenue, wider quarterly loss The company reported third-quarter 2026 revenue of $0 and a net loss of $155,817, versus a loss of $110,845 a year earlier. Diluted EPS was $(0.00). EQUITY | Sep 17, 2026, 05:34 PM UTC M Vitaspring Biomedical appoints Chen CEO, Shih chairman after resignation The company appointed Jing-Zhou Chen as chief executive officer, president, chief financial officer and secretary, and elected Shao-Hsiang Shih as chairman. The changes followed Dr. Ssu-Chuan Lai’s resignation from multi EQUITY | Sep 10, 2026, 05:23 PM UTC